Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $397M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VOR BIOPHARMA INC | 6,692,429 | $125M | 31.4% | $43.10 | — | COM | 929033108 |
| — | AKOUOS INC | 4,135,784 | $51.9M | 13.1% | $22.50 | — | COM | 00973J101 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,798,066 | $37.74M | 9.5% | $7.13 | +188.0% | COM | 45166A102 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $32.98M | 8.3% | $20.70 | — | COM | 438083107 |
| ARVN | ARVINAS INC | 400,000 | $30.8M | 7.8% | $29.28 | +137.1% | COM | 04335A105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,362,286 | $25.68M | 6.5% | $19.04 | -7.7% | COM | 22663K107 |
| CABA | CABALETTA BIO INC | 2,984,263 | $25.66M | 6.5% | $11.85 | -17.1% | COM | 12674W109 |
| — | IMPEL NEUROPHARMA INC | 2,884,791 | $25.53M | 6.4% | $8.85 | — | COM | 45258K109 |
| — | SCPHARMACEUTICALS INC | 3,831,474 | $23.41M | 5.9% | $5.92 | — | COM | 810648105 |
| JANX | JANUX THERAPEUTICS INC | 446,266 | $11.13M | 2.8% | $22.27 | 0.0% | COM | 47103J105 |
| — | CIDARA THERAPEUTICS INC | 2,006,511 | $4.053M | 1.0% | $3.84 | — | COM | 171757107 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3.64M | 0.9% | $10.17 | — | COM CL A | 33836P105 |